Gadd45γ is androgen-responsive and growth-inhibitory in prostate cancer cells

Molecular and Cellular Endocrinology

Volumn 213, Issue 2, 2004, Pages 121-129

  Jiang, Feng ^a   Wang, Zhou ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Androgen responsive gene; GADD45 ; Growth inhibition; Prostate

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; BICALUTAMIDE; CYCLOHEXIMIDE; DNA; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; PROTEIN; SIGNAL PEPTIDE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL LINE; CELL STRUCTURE; DNA DAMAGE; GENE IDENTIFICATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RECEPTOR BINDING; RECEPTOR BLOCKING; UPREGULATION; CELL DIFFERENTIATION; CELL DIVISION; CELL SIZE; DRUG EFFECT; MALE; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ANDROGENS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE, TUMOR; CELL SIZE; CYCLOHEXIMIDE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; PROSTATIC NEOPLASMS; PROTEIN BIOSYNTHESIS; PROTEINS; UP-REGULATION;

EID: 1142309824     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2003.10.050     Document Type: Article

References (40)

1. Azam N., Vairapandi M., Zhang W., Hoffman B., Liebermann D.A. Interaction of CR6 (GADD45 gamma) with proliferating cell nuclear antigen impedes negative growth control. J. Biol. Chem. 276:2001;2766-2774.
2. Bang Y.J., Pirnia F., Fang W.G., Kang W.K., Sartor O., Whitesell L., Ha M.J., Tsokos M., Sheahan M.D., Nguyen P.et al. Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. Proc. Natl. Acad. Sci. U.S.A. 91:1994;5330-5334.
3. Bauer J.A., Thompson T.A., Church D.R., Ariazi E.A., Wilding G. Growth inhibition and differentiation in human prostate carcinoma cells induced by the Vitamin D analog 1 alpha, 24-dihydroxyvitamin D2. Prostate. 55:2003;159-167.
4. Brinkmann A.O., Blok L.J., de Ruiter P.E., Doesburg P., Steketee K., Berrevoets C.A., Trapman J. Mechanisms of androgen receptor activation and function. J. Steroid Biochem. Mol. Biol. 69:1999;307-313.
5. Bruchovsky N., Lesser B., Van Doorn E., Craven S. Hormonal effects on cell proliferation in rat prostate. Vitam. Horm. 33:1975;61-102.
6. Bruyninx M., Ammar H., Reiter E., Cornet A., Closset J. Genes upregulated during castration-induced rat prostatic apoptosis: cloning and characterization of new cDNAs. Br. J. Urol. Int. 85:2000;1134-1142.
7. Cox M.E., Deeble P.D., Lakhani S., Parsons S.J. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression. Cancer Res. 59:1999;3821-3830.
8. Culig Z., Klocker H., Bartsch G., Hobisch A. Androgen receptors in prostate cancer. Endocr. Relat. Cancer. 9:2002;155-170.
9. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell. 103:2000;239-252.
10. Denmeade S.R., Sokoll L.J., Dalrymple S., Rosen D.M., Gady A.M., Bruzek D., Ricklis R.M., Isaacs J.T. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models. Prostate. 54:2003;249-257.
11. Eder I.E., Culig Z., Putz T., Nessler-Menardi C., Bartsch G., Klocker H. Molecular biology of the androgen receptor: from molecular understanding to the clinic. Eur. Urol. 40:2001;241-251.
12. Feldman B.J., Feldman D. The development of androgen-independent prostate cancer. Nat. Rev. Cancer. 1:2001;34-45.
13. Geck P., Szelei J., Jimenez J., Lin T.M., Sonnenschein C., Soto A.M. Expression of novel genes linked to the androgen-induced, proliferative shutoff in prostate cancer cells. J. Steroid Biochem. Mol. Biol. 63:1997;211-218.
14. Hoffmeyer A., Piekorz R., Moriggl R., Ihle J.N. Gadd45 gamma is dispensable for normal mouse development and T-cell proliferation. Mol. Cell. Biol. 21:2001;3137-3143.
15. Huggins C. Endocrine-induced regression of cancers. Cancer Res. 27:1967;1925-1930.
16. Jemal A., Thomas A., Murray T., Thun M. Cancer statistics, 2002. CA Cancer J. Clin. 52:2002;23-47.
17. Jiang F., Wang Z. Identification of androgen-responsive genes in the rat ventral prostate by complementary deoxyribonucleic acid subtraction and microarray. Endocrinology. 144:2003;1257-1265.
18. Jiang F., Yang L., Cai X., Cyriac J., Shechter I., Wang Z. Farnesyl diphosphate synthase is abundantly expressed and regulated by androgen in rat prostatic epithelial cells. J. Steroid Biochem. Mol. Biol. 78:2001;123-130.
19. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 298:2002;1911-1912.
20. Kerr J.F., Searle J. Deletion of cells by apoptosis during castration-induced involution of the rat prostate. Virchows Arch. B: Cell Pathol. 13:1973;87-102.
21. Kokontis J.M., Hay N., Liao S. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest. Mol. Endocrinol. 12:1998;941-953.
22. Kollara A., Diamandis E.P., Brown T.J. Secretion of endogenous kallikreins 2 and 3 by androgen receptor-transfected PC-3 prostate cancer cells. J. Steroid Biochem. Mol. Biol. 84:2003;493-502.
23. Kozlowski J.M., Ellis W.J., Grayhack J.T. Advanced prostatic carcinoma. Early versus late endocrine therapy. Urol. Clin. North Am. 18:1991;15-24.
24. Lee C., Sutkowski D.M., Sensibar J.A., Zelner D., Kim I., Amsel I., Shaw N., Prins G.S., Kozlowski J.M. Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone. Endocrinology. 136:1995;796-803.
25. Liao X., Thrasher J.B., Pelling J., Holzbeierlein J., Sang Q.X., Li B. Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer. Endocrinology. 144:2003;1656-1663.
26. Liebermann D.A., Hoffman B. Myeloid differentiation (MyD)/growth arrest DNA damage (GADD) genes in tumor suppression. Leukemia. 16:2002;527-541.
27. Lu B., Yu H., Chow C., Li B., Zheng W., Davis R.J., Flavell R.A. GADD45gamma mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector TH1 cells. Immunity. 14:2001;583-590.
28. Masiello D., Cheng S., Bubley G.J., Lu M.L., Balk S.P. Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor. J. Biol. Chem. 277:2002;26321-26326.
29. Nakayama K., Hara T., Hibi M., Hirano T., Miyajima A. A novel oncostatin M-inducible gene OIG37 forms a gene family with MyD118 and GADD45 and negatively regulates cell growth. J. Biol. Chem. 274:1999;24766-24772.
30. Nelson P.S., Clegg N., Arnold H., Ferguson C., Bonham M., White J., Hood L., Lin B. The program of androgen-responsive genes in neoplastic prostate epithelium. Proc. Natl. Acad. Sci. U.S.A. 99:2002;11890-11895.
31. Pang S.T., Dillner K., Wu X., Pousette A., Norstedt G., Flores-Morales A. Gene expression profiling of androgen deficiency predicts a pathway of prostate apoptosis that involves genes related to oxidative stress. Endocrinology. 143:2002;4897-4906.
32. Prins G.S. Molecular biology of the androgen receptor. Mayo Clin. Proc. 75(Suppl. 2):2000;S32-S35.
33. Sandford N.L., Searle J.W., Kerr J.F. Successive waves of apoptosis in the rat prostate after repeated withdrawal of testosterone stimulation. Pathology. 16:1984;406-410.
34. Suzuki M., Watanabe T.K., Fujiwara T., Nakamura Y., Takahashi E., Tanigami A. Molecular cloning, expression, and mapping of a novel human cDNA, GRP17, highly homologous to human gadd45 and murine MyD118m. J. Hum. Genet. 44:1999;300-303.
35. Swinnen J.V., Van Veldhoven P.P., Esquenet M., Heyns W., Verhoeven G. Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP. Endocrinology. 137:1996;4468-4474.
36. Takekawa M., Saito H. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell. 95:1998;521-530.
37. Veldscholte J., Berrevoets C.A., Ris-Stalpers C., Kuiper G.G., Jenster G., Trapman J., Brinkmann A.O., Mulder E. The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens. J. Steroid Biochem. Mol. Biol. 41:1992;665-669.
38. Wang Z., Tufts R., Haleem R., Cai X. Genes regulated by androgen in the rat ventral prostate. Proc. Natl. Acad. Sci. U.S.A. 94:1997;12999-13004.
39. Wilding G., Chen M., Gelmann E.P. Aberrant response in vitro of hormone-responsive prostate cancer cells to antiandrogens. Prostate. 14:1989;103-115.
40. Yang Q., Manicone A., Coursen J.D., Linke S.P., Nagashima M., Forgues M., Wang X.W. Identification of a functional domain in a GADD45-mediated G2/M checkpoint. J. Biol. Chem. 275:2000;36892-36898.